The effects of fibrates on lipoprotein and hemostatic coronary risk factors

This publication has 89 references indexed in Scilit:

• Stable isotopes show a direct relation between VLDL apoB overproduction and serum triglyceride levels and indicate a metabolically and biochemically coherent basis for familial combined hyperlipidemia.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
• Fenofibrate and LDL metabolic heterogeneity in hypercholesterolemia.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
• The pathogenesis of atherosclerosis: a perspective for the 1990s
  Nature, 1993
• Double-blind comparison of bezafibrate versus placebo in male volunteers with hyperlipoproteinemia
  Atherosclerosis, 1992
• Effects of Gemfibrozil and Other Fibric Acid Derivatives on Blood Lipids and Lipoproteins
  The Journal of Clinical Pharmacology, 1991
• Lipoprotein composition changes induced by fenofibrate in dysbetalipoproteinemia type III
  Atherosclerosis, 1989
• Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
  New England Journal of Medicine, 1987
• Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial Infarction
  New England Journal of Medicine, 1985
• Thrombosis and Acute Coronary-Artery Lesions in Sudden Cardiac Ischemic Death
  New England Journal of Medicine, 1984
• Quantitative studies of ver low densit lipoprotein: conversion to low densit lipoprotein in normal controls and primar hperlipidaemic states and the role of direct secretion of low densit lipoprotein in heterozgous familial hpercholesterolaemia
  European Journal of Clinical Investigation, 1980